The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan

American Journal of Surgery

Volumn 195, Issue 1, 2008, Pages 53-60

  Sasagawa, Tsuyoshi ^a   Solano, Horacio ^b   Vega, Walter ^b   Mena, Fernando ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

Author keywords

Costa Rica; Extended lymph node dissection; Gastric cancer

Indexed keywords

ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; COSTA RICA; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; JAPANESE; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; SURGEON; SURGICAL MORTALITY; TUMOR LOCALIZATION; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; COSTA RICA; FEMALE; GASTRECTOMY; HUMANS; JAPAN; LYMPH NODE EXCISION; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 36849002037     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.01.028     Document Type: Article

References (35)

1. In: Whelan S.L., Parkin D.M., and Masuyer E. (Eds). Trends in Cancer Incidence and Mortality (1993), IARC Scientific Publications, Lyon, France IARC scientific publications no. 102
2. In: Kurihara M., Aoki K., and Hasamichi S. (Eds). Cancer Mortality Statistics in the World 1950-1985 (1989), The University of Nagoya Press, Nagoya, Japan
3. Sasasgawa T., Solano H., and Mena F. Gastric cancer in Costa Rica. Gastrointest Endosc 50 (1999) 594-595
4. Maruyama K., Okabayashi K., and Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. Worid J Surg 11 (1987) 418-426
5. Dent D.M., Madden M.V., and Price S.K. Randomised comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 75 (1988) 110-112
6. Robertson C.S., Chung S.C.S., Woods S.D.S., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 220 (1994) 176-182
7. Bhonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345 (1995) 745-748
8. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347 (1996) 995-999
9. Bonenkamp J.J., Hermans J., Sassako M., et al. Extended lymph node dissection for gastric cancer. N Engl J Med 340 (1999) 908-914
10. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79 (1999) 1522-1530
11. Hartgrink H.H., van de Velde C.J.H., Putter H., et al. Extended lymph node dissection for gastric cancer: who may benefit?. Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22 (2004) 2069-2077
12. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma 2nd English edition. Gastric Cancer 1 (1998) 10-24
13. Pacelli F., Doglietto G.B., Bellantone R., et al. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80 (1993) 1153-1156
14. Jatzko G.R., Lisborg P.H., Denk H., et al. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 76 (1995) 1302-1312
15. Sasako M., Sano T., Katai H., and Maruyama K. Radical surgery. In: Sugimura T., and Sasako M. (Eds). Gastric Cancer (1997), Oxford University Press, Oxford 223-248
16. Schmid A., Thybush A., Henne-Bruns D., et al. Gastrectomy with radical D2 lymph node excision-effective and economically standardized therapy of adenocarcinoma of the stomach. Langenbecks Arch Chir Suppel Kongressbd 114 (1997) 1066-1068
17. Siewert J.R., Böttcher K., Stein H.J., et al., German Gastric Carcinoma Study Group. Relevant prognostic factors in gastric cancer: ten-year of the German Gastric Cancer Study. Ann Surg 228 (1998) 449-461
18. Yildirim E., Celen O., and Berberogle U. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?. J Am Coll Surg 192 (2001) 23-37
19. Degiuli M., Sasako M., Ponti A., et al., Italian Gastric Cancer Study Group (IGCSG). Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 90 (2004) 1727-1732
20. Ajani J.A. Operate on my stomach cancer?. Oh, no-not you, not yet!. J Clin Oncol 22 (2004) 1763-1764
21. Kappas A.M., and Roukos D.H. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 9 (2002) 828-830
22. Roukos D.H., Lorenz M., and Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery 123 (1998) 573-578
23. Pugliese R., Maggioni D., Berardi V., et al. Extended (D2) lymphadenectomy in gastric cancer: a five year experience. Int Surg 85 (2000) 209-215
24. Alejandro S., Fernando M., Regueira, et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10 (2003) 219-222
25. Degiuli M., Sasako M., Calgaro M., et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol 30 (2004) 303-308
26. Fujii M., Sasaki J., and Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 2 (1999) 151-157
27. Sano T., Katai H., Sasako M., et al. One thousand consecutive gastrectomies with out operative mortality. Br J Surg 89 (2002) 123
28. Sano T., Sasako M., Yamamoto S., et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized control trial comparing D2 and extended para-aortic lymphadenectomy-Japan clinical oncology group study 9501. J Clin Oncol 22 (2004) 2767-2773
29. Bittner R., Butters M., Ulrich M., et al. Total gastrectomy: updated operative mortality and long term survival with particular reference to patients older than 70 years of age. Ann Surg 224 (1996) 37-42
30. Sorcide J.A., van Heerden J.A., Burgart L.J., et al. Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure. Arch Surg 131 (1996) 481-487
31. Sasako M. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 84 (1997) 1567-1571
32. Brady M.S., Rogatko A., Dent L.L., and Shiu M.H. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 126 (1991) 359-364
33. Viste A., Haugstvedt T., Eide G.E., and Soreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 207 (1988) 7-13
34. Stipa S., Di Giorigio A., Ferri M., et al. Results of curative gastrectomy for carcinoma. J Am Coll Surg 179 (1994) 567-572
35. Grossmann E.M., Longo W.E., Virgo K.S., et al. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery 131 (2002) 484-490